Malignant Lung Neoplasm — Trials

Malignant Lung Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

11,122 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 2,648
Recruiting: 1,431
Ph III recruiting: 179
Growth YoY: +7.9%
Industry share: 37%
Top sponsor: AstraZeneca
Termination share: 34.8%
Trials / 1,000 deaths: 20.1 USA 2023 cdc-uscs

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (1,489)

clinicaltrialsPublishedShowing 51–100 of 264 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07722182	Navigation Bronchoscopy Guided Microwave Ablation Versus SBRT in Early NSCLC	not yet recruiting	Phase 2	100	Chinese University of Hong KongOTHER	1	Jul 24, 2026	clinicaltrials
NCT07720167	Cemiplimab for Clinical Stage I, 2-3.9cm, Non-Small Cell Lung Cancer	not yet recruiting	Phase 2	38	Medical University of South CarolinaOTHER	1	Jul 22, 2026	clinicaltrials